AP-414

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAP-414
Drug Alias NameAP-414
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMast cell degranulation inhibitors
TargetsUpdating
Therapy Area/IndicationsHypersensitivityAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAriad Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAriad Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHypersensitivityAsthma

Other Information

ATC CodeN/A
Related LinksN/A